Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wuwei Yixin Granules for Stable Angina in Coronary Artery Disease (Phase II, RCT)
CTR20250462Phase 2Active
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd.
- Start
- Apr 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Wuwei Yixin Granules in coronary arteriosclerosis, angina pectoris, sponsored by Jiangsu Kanion Pharmaceutical Co., Ltd.. Started Apr 2025; status: active.
02
Drugs
Wuwei Yixin Granules
03
Conditions
coronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on CTR20250462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250462.